STIMULAN® Rapid Cure can now be used with both a wider range of antibiotics and also with antifungals in India STIMULAN® Rapid Cure can be placed in bone and surrounding soft tissue to assist in wound healing and treatment of infection Keele, UK, 25 November 2025 – Biocomposites, an international medical devices company that engineers, […]
COPENHAGEN, Denmark, Jan. 9, 2024 – The Novo Nordisk Foundation is committing up to USD 25 million to support the early-stage development of innovative tools to prevent, diagnose and treat the most dangerous drug-resistant bacterial infections. The three-year grant will go to the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), the leading global non-profit public-private partnership in this […]
Tenmile and Novo Holdings are core investors Cristina Larkin, Bruce Montgomery, and Michael Lamprecht to join the Board of Directors Revagenix, Inc. is advancing a focused pipeline of antibiotic programs designed to treat infections caused by multidrug-resistant organisms SAN FRANCISCO, Jan. 5, 2024 – Revagenix, Inc., a biopharmaceutical company dedicated to the discovery and development of novel antibiotics, today announced […]
Research findings from two studies demonstrate the antimicrobial effectiveness of STIMULAN® and genex®, when mixed with antibiotics Keele, UK, 12 April 2022,– Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces the acceptance of two posters at the 32nd European […]
Combination antibiotics released from STIMULAN completely kill antibiotic resistant biofilms STIMULAN is the only calcium matrix antibiotic carrier approved for use in bone and soft tissue in the EU, UK, Canada, and Saudi Arabia Keele, UK, 15 March 2022 – Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use […]
